Meanwhile, On The Front Lines...

While politicians are squabbling over whether to allow an ounce or a dram of stem cell research to proceed, there are promising signs for future growth in the business and research communities. Newsday notes that the New Jersey Stem Cell Research Endowment Fund is planning an initiative to assist collaboration between academic researchers and biotechnology companies. Partnerships between the two sides are essential to the funding process and the task of turning new medical technologies into viable therapies. Now if the politicians would just stand aside, I'd be far happier about the future of regenerative medicine, health and longevity.


Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.